Skip to content
10-Q

Quarterly Report

CARDIFF ONCOLOGY, INC. CRDF

0000950170-25-066886

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 66.53M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $55.79M
Short Term Investments Q1 2025 · Dec 31, 2024 $40.28M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $24.1M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $51.47M
Current Liabilities Q1 2025 · Mar 31, 2025 $13.29M
Current Liabilities Q1 2025 · Dec 31, 2024 $13.43M
Total Liabilities Q1 2025 · Mar 31, 2025 $13.93M
Total Liabilities Q1 2025 · Dec 31, 2024 $14.24M
Current Assets Q1 2025 · Mar 31, 2025 $82.71M
Current Assets Q1 2025 · Dec 31, 2024 $95.05M
Total Assets Q1 2025 · Mar 31, 2025 $84.81M
Total Assets Q1 2025 · Dec 31, 2024 $97.19M
Shares Diluted Q1 2025 · Mar 31, 2024 44.68M sh
Capex Q1 2025 · Mar 31, 2024 $80K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$7.74M
Stockholders Equity Q1 2025 · Mar 31, 2024 $60.89M
Stockholders Equity Q1 2025 · Dec 31, 2023 $69.74M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.22
Eps Basic Q1 2025 · Mar 31, 2024 −$0.22
Sga Expense Q1 2025 · Mar 31, 2024 $3.13M
Net Income Q1 2025 · Mar 31, 2024 −$10.01M
Operating Income Q1 2025 · Mar 31, 2024 −$10.93M
Revenue Q1 2025 · Mar 31, 2024 $205K